Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191242 · ClinicalTrials.gov registry record
Methadone Monitoring for Insights Into Adverse Events
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 31
- Enrollment target
NCT01191242: Completed study, sponsored by Intermountain Health Care.
NCT01191242 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191242 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study will look at blood samples for drug levels and genetic components and EKG's (a noninvasive test which reveals heart rhythm). There will be no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-05 |
What the finished NCT01191242 record still lists
NCT01191242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01191242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01191242 about?
NCT01191242 is a clinical study titled "Methadone Monitoring for Insights Into Adverse Events". Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study ...
What is the current status of trial NCT01191242?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-08. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01191242?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia